Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (...
German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China.
Chinese state media have confirmed that He Jiankui, the scientist who claimed to have genetically modified babies to prevent them from contracting...
The European Commission has decided to approve a label extension in the region for Orkambi in the treatment of cystic fibrosis (CF), expanding the...
A judge has thrown US multinational AbbVie’s case against NHS England’s hepatitis C procurement process, out of court.
Top ten stories on Pharmafile.com this week!
As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm Cephea Valve Technologies, acting...
Novo Nordisk Pharmatech A/S and DKSH have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across Asia Pacific.
Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, according to new...
Verona Pharma has seen its shares crater following the Phase 2 failure of its nebulised ensifentrine, known as RPL554, in combination with...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches